Arcturus Therapeutics (ARCT) revenue breakdown
By product, Collaboration Revenue is the largest at 82% of fiscal 2025 revenue; Grant Revenue grew fastest, 293% a year over 3 years.
Revenue by product
Fiscal years, as Arcturus Therapeutics reports them in its 10-K filings; fiscal 2025 total $82M.
| Products | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|
| Collaboration Revenue | $206M | $158M | $138M | $67M | 82% |
| Grant Revenue | $244,000 | $9M | $14M | $15M | 18% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for ARCT.
Open ARCT in InvestinglyQuestions
Where does Arcturus Therapeutics make its money?
In fiscal 2025, by product: Collaboration Revenue $67M, Grant Revenue $15M.
From Arcturus Therapeutics's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.